The ability of AIM2 to recognize dsDNA in conjunction with the cGAS-STING pathway and initiate inflammasome assembly underscores its importance in neuroinflammatory processes, highlighting its potential as a therapeutic target in various neurological disorders [41]. The gene discussed is CGAS; the disease is nervous system disorder.